Search Results (3)

Pomegranate (Punica granatum L.), is renowned for its bioactive compounds, offering significant potential in cosmetic applications due to its antioxidant, anti-inflammatory, and antimicrobial properties. This study presents a sustainably sourced cosmetic ingredient developed by enriching pomegranate seed oil with peel powder using optimized ultrasonication, followed by encapsulation in alginate nanobeads and integration into a minimalist hydrogel formulation. A Box–Behnken experimental design was employed to optimize ultrasonication parameters (15 min, 90% power, 202 mg/mL powder-to-oil ratio), yielding an enriched PSO with significantly enhanced total phenolic content (TPC: 69.23 ± 1.66 mg GAE/g), total flavonoid content (TFC: 61.09 ± 1.66 mg QE/g), and robust DPPH antioxidant activity (78.63 ± 3.81%). The enriched oil exhibited enhanced oxidative stability (peroxide value: 5.75 ± 0.30 meq O₂/kg vs. 50.95 ± 0.07 meq O₂/kg for neutral oil), improved fatty acid profile, and significant anti-inflammatory (IC₅₀ = 897.25 µg/mL for NO inhibition) and antibacterial activities. Alginate nanobeads (432.46 ± 12.59 nm, zeta potential: −30.74 ± 3.20 mV) ensured bioactivity preservation, while the hydrogel maintained physicochemical and microbial stability over 60 days under accelerated conditions (40 ± 2 °C, 75 ± 5% RH). This multifunctional formulation, integrating sustainable extraction, advanced encapsulation, and a minimalist delivery system, represents a highly promising natural ingredient for anti-aging and antioxidant cosmetic applications. Full article

Most infectious diseases of the gastrointestinal tract can easily be treated by exploiting the already available antibiotics with the change in administration approach and delivery system. Ciprofloxacin (CIP) is used as a drug of choice for many bacterial infections; however, long-term therapy and off-site drug accumulation lead to an increased risk of tendinitis and peripheral neuropathy. To overcome this issue, nanotechnology is being exploited to encapsulate antibiotics within polymeric structures, which not only facilitates dose maintenance at the infection site but also limits off-site side effects. Here, sodium alginate (SA) and thiol-anchored chitosan (TC) were used to encapsulate CIP via a calcium chloride (CaCl₂) cross-linker. For this purpose, the B-390 encapsulator was employed in the preparation of nanobeads using a simple technique. The hydrogel-like sample was then freeze-dried, using trehalose or mannitol as a lyoprotectant, to obtain a fine dry powder. Design of Experiment (DoE) was utilized to optimize the nanobead production, in which the influence of different independent variables was studied for their outcome on the polydispersity index (PDI), particle size, zeta potential, and percentage encapsulation efficiency (% EE). In vitro dissolution studies were performed in simulated saliva fluid, simulated gastric fluid, and simulated intestinal fluid. Antibacterial and anti-inflammatory studies were also performed along with cytotoxicity profiling. By and large, the study presented positive outcomes, proving the advantage of using nanotechnology in fabricating new delivery approaches using already available antibiotics. Full article

The aim of this study was to investigate covalent immobilization of horseradish peroxidase (HRP) on magnetic nanoparticles (Mag) encapsulated in calcium alginate beads (MABs) for color degradation, combining easy and fast removal of biocatalyst from the reaction mixture due to its magnetic properties and strong binding due to surface alginate functional groups. MABs obtained by extrusion techniques were analyzed by optical microscopy, FEG-SEM and characterized regarding mechanical properties, magnetization and HRP binding. HRP with initial concentration of 10 mg/g_carrier was successfully covalently bonded on MABs (diameter ~1 mm, magnetite/alginate ratio 1:4), with protein loading of 8.9 mg/g_carrier, immobilization yield 96.9% and activity 32.8 U/g. Immobilized HRP on MABs (HRP-MABs) was then used to catalyze degradation of two anthraquinonic dyes, Acid Blue 225 (AB225) and Acid Violet 109 (AV109), as models for wastewater pollutants. HRP-MABs decolorized 77.3% and 76.1% of AV109 and AB225, respectively after 15 min under optimal conditions (0.097 mM H₂O₂, 200 mg of HRP-MABs (8.9 mg/g_carrier), 0.08 and 0.1 g/mg beads/dye ratio for AV109 and AB225, respectively). Biocatalyst was used for 7 repeated cycles retaining 75% and 51% of initial activity for AB225 and AV109, respectively, showing potential for use in large scale applications for colored wastewater treatment. Full article